Atlas Trials

Oral Berotralstat Expanded Access Program

Clinical trial NCT04428632 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT04428632
Sponsor
BioCryst Pharmaceuticals
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Hereditary AngioedemaHAEProphylaxis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.